Literature DB >> 8926490

Recruitment of mast cells to muscle after mild damage.

J R Gorospe1, B K Nishikawa, E P Hoffman.   

Abstract

We followed the response of muscle following mild intentional injury to determine a temporal sequence of cellular events involved in muscle repair. We found that intramuscular saline injection induced mild damage to muscle which resulted in the gradual recruitment of mast cells. Around the needle track, mast cells appear around 8 h post-injection. Mast cell accumulation were most dramatic immediately neighboring the posterior tibial vessels supplying the injured muscle. Dystrophin-deficient mdx muscle showed mast cell accumulations 3-fold higher than normal muscle, and this number did not change after saline injection. Additionally, we show that stem cell factor (SCF), a known mast cell chemoattractant, is expressed in both normal and mdx muscle at high levels. This steady-state level did not appear to be influenced by injury or dystrophin status. The implications of these findings are discussed as they relate to the repair of injured muscle and to their possible significance in the pathophysiology of Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926490     DOI: 10.1016/0022-510x(95)00255-z

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS.

Authors:  Emiliano Trias; Sofía Ibarburu; Romina Barreto-Núñez; Valentina Varela; Ivan C Moura; Patrice Dubreuil; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  JCI Insight       Date:  2017-10-19

3.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 4.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

Review 5.  Immune-mediated pathology in Duchenne muscular dystrophy.

Authors:  Amy S Rosenberg; Montserrat Puig; Kanneboyina Nagaraju; Eric P Hoffman; S Armando Villalta; V Ashutosh Rao; Lalage M Wakefield; Janet Woodcock
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

Review 6.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

7.  Mast cell tryptase stimulates myoblast proliferation; a mechanism relying on protease-activated receptor-2 and cyclooxygenase-2.

Authors:  Elise Duchesne; Marie-Hélène Tremblay; Claude H Côté
Journal:  BMC Musculoskelet Disord       Date:  2011-10-14       Impact factor: 2.362

8.  Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.

Authors:  Y W Chen; P Zhao; R Borup; E P Hoffman
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

9.  Histopathology and the inflammatory response of European perch, Perca fluviatilis muscle infected with Eustrongylides sp. (Nematoda).

Authors:  Bahram S Dezfuli; Maurizio Manera; Massimo Lorenzoni; Flavio Pironi; Andrew P Shinn; Luisa Giari
Journal:  Parasit Vectors       Date:  2015-04-15       Impact factor: 3.876

Review 10.  Macrophage plasticity and the role of inflammation in skeletal muscle repair.

Authors:  Yacine Kharraz; Joana Guerra; Christopher J Mann; Antonio L Serrano; Pura Muñoz-Cánoves
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.